investment in stocks

RxSight held an IPO

RxSight Company, commercial supplier of premium customizable intraocular lenses, which can be installed after cataract surgery, attracted 118 million dollars, releasing 7,4 million shares in 16 dollars - the minimum price of the stated range from 16 to 18 Dollars.

Immuneering offers more shares at IPO

Preclinical Biotechnology Company Immuneering, specializing in influencing signaling pathways for the treatment of cancer and neurological diseases, attracted 113 million dollars, releasing 7,5 million shares in 15 dollars - within the stated range from 14 to 16 Dollars.

Biotechnology company Eliem Therapeutics announces IPO terms

2 August biotech company Eliem Therapeutics, developing drugs for the treatment of disorders of nervous excitability in phase 2a research, announced the terms of the upcoming IPO. Company headquartered in Redmond, Washington State, plans to attract 81 million dollars, releasing 4,5 million shares at a price from 17 to 19 Dollars.

Core & Main held an IPO at the lowest price 20 Dollars

Leading distributor of pipes and other industrial products for water supply Core & Main attracted 698 million dollars, releasing 34,9 million shares in 20 dollars - the minimum price of the stated range from 20 to 23 Dollars. Taking into account the actual IPO price, the total diluted market value of the company was 4,8 billion dollars.

Biotech company Dynacure unveils IPO terms

12 July Dynacure, French biotechnology company, developing drugs for the treatment of neuromuscular diseases in the ½ phase of research, announced the terms of the upcoming IPO. Company headquartered in Ilkirsch-Graffenstaden, France, plans to attract 100 million dollars, releasing 6,3 million ADS at a cost of 15 to 17 Dollars.

Scroll to Top